Bladder Cancer and Coronary Artery Disease
Conditions
Interventions
group undergoing simultaneous TURBT and coronary artery revascularization:None
Priority TURBT Group:None
Priority Coronary Revascularization Group:None
Sponsors
Beijing Anzhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 Voluntarily participate and provide written informed consent. 2 Ability to comply with the study protocol. 3 Age between 18 and 80 years. 4 Diagnosis of bladder cancer (based on the Bladder Cancer Diagnosis and Treatment Guidelines, 2022 Edition) with concomitant coronary artery disease (according to the diagnostic criteria in the 10th Edition of Internal Medicine), and scheduled for therapeutic transurethral resection of bladder tumor (TURBT) or those undergoing maximal resection for incurable disease.
Exclusion criteria
Exclusion criteria: 1 Patients with consciousness, cognitive, or mental disorders; 2 Patients in the acute phase of disease onset; 3 Patients with severe primary diseases of the liver, kidney, hematopoietic system, nervous system, endocrine system, etc.; 4 Women with positive urine pregnancy test or in lactation period; 5 Patients with bladder cancer (diagnosed according to the "Bladder Cancer Diagnosis and Treatment Guidelines (2022 Edition)") combined with coronary heart disease (diagnosed according to the "Internal Medicine, 10th Edition"), who are scheduled to undergo diagnostic TURBT, transurethral bladder tumor biopsy, radical cystectomy, or partial cystectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular adverse events;refractory hematuria;tumor progression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Countries
China
Contacts
Public ContactNing Zhang
Beijing Anzhen Hospital, Capital Medical University
Outcome results
None listed